Back
Vertex Pharmaceuticals Vs. Equifax Industry Stock Comparison
Buy
62
VRTX
Vertex Pharmaceuticals
Last Price:
402.43
Seasonality Move:
10.13%
Buy
58
EFX
Equifax
Last Price:
220.78
Seasonality Move:
3.45%
Buy
62
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $402.18. The Score for VRTX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Equifax (EFX)
is a Buy
Is Equifax a Buy, Sell or Hold?
- The current Equifax [EFX] share price is $220.67. The Score for EFX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- EFX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $402.18
The current trend is relatively stagnant and VRTX is experiencing slight buying pressure.
EFX Stock Price Chart
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.52 | Sell |
| Relative Strength Index (14 RSI): | 49.75 | Sell |
| Chaikin Money Flow: | 355832 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (394.36 - 409.8) | Buy |
| Bollinger Bands (100): | (395.67 - 430.15) | Sell |
EFX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -9.5 | Sell |
| Relative Strength Index (14 RSI): | 32.85 | Sell |
| Chaikin Money Flow: | -394075 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (223.76 - 257.44) | Sell |
| Bollinger Bands (100): | (235.19 - 262.33) | Sell |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 398.95 | Buy |
| 20-day SMA: | 398.88 | Buy |
| 50-day SMA: | 410.19 | Sell |
| 200-day SMA: | 384.2 | Buy |
| 8-day EMA: | 398.1 | Buy |
| 20-day EMA: | 400.53 | Buy |
| 50-day EMA: | 406.1 | Sell |
| 200-day EMA: | 386.17 | Buy |
EFX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 223.15 | Sell |
| 20-day SMA: | 235.64 | Sell |
| 50-day SMA: | 252.36 | Sell |
| 200-day SMA: | 221.7 | Sell |
| 8-day EMA: | 224.26 | Sell |
| 20-day EMA: | 233.33 | Sell |
| 50-day EMA: | 243.24 | Sell |
| 200-day EMA: | 230.59 | Sell |
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.30 per share, an increase this year of $1.62 per share, and an increase next year of $1.37 per share.
Equifax Earnings Growth & EFX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.25 per share, an increase this year of $0.73 per share, and an increase next year of $2.17 per share.
Vertex Pharmaceuticals Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Equifax Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||